Vaxart, Inc. Uncategorized Contracts & Agreements
72 Contracts & Agreements
- Amendment to Letter Agreement dated May 2, 2023 between Andrei Floroiu and Vaxart, Inc (Filed With SEC on May 4, 2023)
- Description of Securities of the Registrant (Filed With SEC on March 15, 2023)
- Offer Letter, dated December 5, 2022, by and between the Company and Phillip Lee (Filed With SEC on March 15, 2023)
- Description of Securities of the Registrant (Filed With SEC on February 24, 2022)
- Offer letter, dated January 18, 2022, by and between the Company and Edward Berg (Filed With SEC on February 24, 2022)
- Offer Letter, dated August 16, 2021, by and between the Company and James Cummings MD (Filed With SEC on November 4, 2021)
- Description of Securities of the Registrant (Filed With SEC on February 25, 2021)
- OPEN MARKET SALE AGREEMENTSM (Filed With SEC on October 14, 2020)
- Letter Agreement, dated June 14, 2020, between Vaxart, Inc. and Andrei Floroiu (Filed With SEC on June 15, 2020)
- Offer Letter, dated May 1, 2006, by and between the Company and Dr. Sean Tucker (Filed With SEC on May 12, 2020)
- Offer Letter, dated March 26, 2018, by and between the Company and Margaret Echerd (Filed With SEC on May 12, 2020)
- Letter dated December 27, 2018, from the Company to Margaret Echerd (Filed With SEC on May 12, 2020)
- Description of Securities of the Registrant (Filed With SEC on March 19, 2020)
- Engagement Letter, dated as of January 25, 2019, by and between Vaxart, Inc. and H.C. Wainwright & Co., LLC., as amended (Filed With SEC on March 20, 2019)
- Form of Placement Warrants (Filed With SEC on March 20, 2019)
- PROTECTIVE RIGHTS AGREEMENT (Filed With SEC on April 26, 2016)
- Certain information contained in this document, marked by ***, is filed with the SEC pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended (Filed With SEC on May 10, 2013)
- Certain information contained in this document, marked by ***, is filed with the SEC pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended (Filed With SEC on May 10, 2013)
- Certain information contained in this document, marked by ***, is filed with the SEC pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended (Filed With SEC on May 10, 2013)
- Certain information contained in this document, marked by ***, is filed with the SEC pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended (Filed With SEC on May 10, 2013)
- SUPPORT AGREEMENT (Filed With SEC on September 18, 2012)
- 0.669212231 x (Filed With SEC on August 8, 2012)
- FIRST AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on April 26, 2012)
- 0.669212231 x (Filed With SEC on April 23, 2012)
- NABI BIOPHARMACEUTICALS 12276 Wilkins Avenue Rockville, Maryland 20852 Dated March 16, 2011 (Filed With SEC on March 22, 2011)
- NABI BIOPHARMACEUTICALS 12276 WILKINS AVENUE (Filed With SEC on May 6, 2009)
- FOURTH AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on August 6, 2008)
- NABI BIOPHARMACEUTICALS 12276 WILKINS AVENUE (Filed With SEC on August 6, 2008)
- NABI BIOPHARMACEUTICALS 12276 Wilkins Avenue (Filed With SEC on May 8, 2008)
- Nabi Biopharmaceuticals 12276 Wilkins Avenue (Filed With SEC on May 8, 2008)
- Nabi Biopharmaceuticals 5800 Park of Commerce Boulevard, N.W. (Filed With SEC on February 28, 2008)
- TRANSITION/TERMINATION AGREEMENT BY AND BETWEEN (Filed With SEC on February 28, 2008)
- [signature page follows] (Filed With SEC on December 10, 2007)
- RIGHT OF FIRST NEGOTIATION/REFUSAL AGREEMENT (Filed With SEC on December 10, 2007)
- SECOND AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on August 2, 2007)
- THIRD AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on August 2, 2007)
- NABI BIOPHARMACEUTICALS 5800 Park of Commerce Boulevard, N.W. (Filed With SEC on August 2, 2007)
- NABI BIOPHARMACEUTICALS 5800 PARK OF COMMERCE BOULEVARD, N.W. (Filed With SEC on August 2, 2007)
- Nabi Biopharmaceuticals 5800 Park of Commerce Boulevard, N.W. (Filed With SEC on May 3, 2007)
- - 2 - (Filed With SEC on May 3, 2007)
